Search for an ETF or holding
QUEST PHARMATECH INC. (QPT.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 5 million CAD (micro-cap).
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.